ORBIMED ADVISORS LLC – SPDR S&P Biotech ETF Transaction History
ORBIMED ADVISORS LLC portfolio value:
$6.06M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+6.80%
quarter
SPDR S&P Biotech ETF 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -31.66% | -35.4K shares | -2.24M | $79.32 | 76.4K |
Q2 2022 | share | 0.00% | 0 shares | -1.74M | $74.27 | 111.8K | |
Q1 2022 | share | Decrease | -88.93% | -897.9K shares | -102.99M | $89.88 | 111.8K |
Q4 2021 | share | Decrease | -5.25% | -56K shares | -20.92M | $113.24 | 1.00M |
Q3 2021 | share | Increase | +13.89% | 130K shares | 7.27M | $125.71 | 1.06M |
Q2 2021 | share | Increase | 0.00% | 935.7K shares | 126.69M | $135.4 | 935.7K |
Q2 2020 | share | Decrease | -100.00% | -127.2K shares | -9.85M | $111.7 | 0 |
Q1 2020 | call | Decrease | -100.00% | -110K shares | -10.46M | $77.26 | 0 |
Q1 2020 | share | 0.00% | 0 shares | -2.24M | $77.26 | 127.2K | |
Q4 2019 | call | Increase | 0.00% | 110K shares | 10.46M | $94.88 | 110K |
Q4 2019 | share | Increase | 0.00% | 127.2K shares | 12.09M | $94.88 | 127.2K |
Q3 2016 | share | Decrease | -100.00% | -745.3K shares | -40.30M | $65.79 | 0 |
Q2 2016 | share | Decrease | -24.04% | -235.9K shares | -10.38M | $53.65 | 745.3K |
Q1 2016 | share | Increase | 0.00% | 981.2K shares | 50.68M | $51.2 | 981.2K |